Enact director granted 139 deferred stock units
Enact Holdings director Michael A. Bless reported an acquisition of 139 Deferred Stock Units on Enact common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Enact Holdings director Michael A. Bless reported an acquisition of 139 Deferred Stock Units on Enact common stock. The units were added under a director award agreement through reinvestment of a cash dividend paid on March 19, 2026 at $0.21 per share. After this award, Bless holds 26,631.538 Deferred Stock Units, which become payable in Enact common shares one year after his termination of service as a director.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Stock Units | 139 | $0.00 | $0.00 |
Footnotes (2)
- F1. Deferred Stock Units become payable in shares of Common Stock one year after termination of service as a director.
- F2. Additional deferred stock units acquired pursuant to reinvestment terms under the director award agreement from a dividend paid on March 19, 2026, at $0.21 per share.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Enact Holdings (ACT) report for Michael A. Bless?
How many Deferred Stock Units does Michael A. Bless hold after this Enact (ACT) Form 4 filing?
When do Michael A. Bless’s Enact (ACT) Deferred Stock Units become payable?
How were the 139 Enact (ACT) Deferred Stock Units for Michael A. Bless determined?
Does the Enact (ACT) Form 4 show any stock sales by Michael A. Bless?
AI-generated analysis. How Rhea-AI works. Not financial advice.